Hamburg - Delayed Quote EUR

Bristol-Myers Squibb Co (BRM.HM)

Compare
56.28 +1.06 (+1.92%)
At close: November 22 at 5:25 PM GMT+1
Advanced Chart
Loading Chart for BRM.HM
DELL
  • Previous Close 55.22
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 56.45
  • Volume 0
  • Avg. Volume 93
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 6, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: BRM.HM

View More
View More

Performance Overview: BRM.HM

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BRM.HM
28.10%
S&P 500
25.15%

1-Year Return

BRM.HM
33.43%
S&P 500
31.54%

3-Year Return

BRM.HM
23.88%
S&P 500
27.06%

5-Year Return

BRM.HM
33.51%
S&P 500
92.34%

Compare To: BRM.HM

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

BRM.HM
Bristol-Myers Squibb Co
56.28
+1.92%
Mkt Cap EUR -
Industry Drug Manufacturers—General
ABBV.MX
AbbVie Inc.
3,633.00
+3.65%
Mkt Cap MXN 6.42T
Industry Drug Manufacturers—General
PFE.CL
Pfizer Inc.
112,860.00
+2.15%
Mkt Cap COP -
Industry Drug Manufacturers—General
4AB.F
AbbVie Inc.
170.72
+4.02%
Mkt Cap EUR 301.686B
Industry Drug Manufacturers—General
PFE.DE
Pfizer Inc.
24.68
+3.76%
Mkt Cap EUR 139.833B
Industry Drug Manufacturers—General
SNY
Sanofi
48.28
+0.63%
Mkt Cap 121.047B
Industry Drug Manufacturers—General
GSK
GSK plc
33.96
+0.77%
Mkt Cap 69.287B
Industry Drug Manufacturers—General
GILD
Gilead Sciences, Inc.
90.19
+0.48%
Mkt Cap 112.401B
Industry Drug Manufacturers—General
AMGN
Amgen Inc.
294.53
+1.60%
Mkt Cap 158.32B
Industry Drug Manufacturers—General
MRK
Merck & Co., Inc.
99.18
-0.68%
Mkt Cap 250.89B
Industry Drug Manufacturers—General
ABBV
AbbVie Inc.
176.95
+3.04%
Mkt Cap 312.695B
Industry Drug Manufacturers—General

Statistics: BRM.HM

View More

Valuation Measures

Annual
As of 11/22/2024

  • Market Cap

    114.06B

  • Enterprise Value

    155.43B

  • Trailing P/E

    --

  • Forward P/E

    8.44

  • PEG Ratio (5yr expected)

    2.06

  • Price/Sales (ttm)

    2.52

  • Price/Book (mrq)

    6.97

  • Enterprise Value/Revenue

    3.43

  • Enterprise Value/EBITDA

    32.09

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: BRM.HM

View More
View More

Company Insights: BRM.HM

Research Reports: BRM.HM

View More
View More

People Also Watch

BRM.DE Bristol-Myers Squibb Company
56.46
+2.21%
 
4AB.F AbbVie Inc.
170.72
+4.02%
 
LLY.HA Eli Lilly and Co
720.60
+1.52%
 
BRM.MU Bristol-Myers Squibb Co
55.48
+0.89%
 
LLY.HM Eli Lilly and Co
720.70
+1.51%
 
4AB.DE AbbVie Inc.
171.54
+5.41%
 
BRM.F Bristol-Myers Squibb Company
56.07
+2.02%
 
GIS.DE Gilead Sciences, Inc.
86.23
+1.38%
 
BRM.DU Bristol-Myers Squibb Co
56.05
+1.19%
 
PFE.HA Pfizer Inc
24.67
+3.74%
 
LLY.MU Eli Lilly and Co
724.70
+1.37%
 
SNW.DE Sanofi
93.15
+2.58%
 
IDP.F Biogen Inc.
152.90
+1.93%
 
BMY.BA Bristol-Myers Squibb Company
21,625.00
+0.12%
 
LLY.F Eli Lilly and Company
717.30
+0.24%
 
BRM.BE Bristol-Myers Squibb Co
55.49
+1.52%